The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug

SM Johnson, S Connelly, C Fearns, ET Powers… - Journal of molecular …, 2012 - Elsevier
Transthyretin (TTR) is one of the many proteins that are known to misfold and aggregate (ie,
undergo amyloidogenesis) in vivo. The process of TTR amyloidogenesis causes nervous …

Protein kinetic stability

JM Sanchez-Ruiz - Biophysical chemistry, 2010 - Elsevier
The relevance of protein stability for biological function and molecular evolution is widely
recognized. Protein stability, however, comes in two flavours: thermodynamic stability, which …

Inhibition of amyloid formation

T Härd, C Lendel - Journal of molecular biology, 2012 - Elsevier
Amyloid is aggregated protein in the form of insoluble fibrils. Amyloid deposition in human
tissue—amyloidosis—is associated with a number of diseases including all common …

Transthyretin: the servant of many masters

JN Buxbaum, N Reixach - Cellular and molecular life sciences, 2009 - Springer
Abstract Transthyretin (TTR)(formerly, thyroxine binding prealbumin) is an evolutionarily
conserved serum and cerebrospinal fluid protein that transports holo-retinol-binding protein …

Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases–progress and prognosis

SL Lindquist, JW Kelly - Cold Spring Harbor perspectives …, 2011 - cshperspectives.cshlp.org
Maintaining the proteome to preserve the health of an organism in the face of developmental
changes, environmental insults, infectious diseases, and rigors of aging is a formidable task …

Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate

NP Grimster, S Connelly, A Baranczak… - Journal of the …, 2013 - ACS Publications
Molecules that bind selectively to a given protein and then undergo a rapid chemoselective
reaction to form a covalent conjugate have utility in drug development. Herein a library of 1 …

Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses

S Connelly, S Choi, SM Johnson, JW Kelly… - Current opinion in …, 2010 - Elsevier
Small molecules that bind to normally unoccupied thyroxine (T4) binding sites within
transthyretin (TTR) in the blood stabilize the tetrameric ground state of TTR relative to the …

Current and future treatment of amyloid diseases

M Ankarcrona, B Winblad, C Monteiro… - Journal of internal …, 2016 - Wiley Online Library
There are more than 30 human proteins whose aggregation appears to cause degenerative
maladies referred to as amyloid diseases or amyloidoses. These disorders are named after …

A Fluorogenic Aryl Fluorosulfate for Intraorganellar Transthyretin Imaging in Living Cells and in Caenorhabditis elegans

A Baranczak, Y Liu, S Connelly, WGH Du… - Journal of the …, 2015 - ACS Publications
Fluorogenic probes, due to their often greater spatial and temporal sensitivity in comparison
to permanently fluorescent small molecules, represent powerful tools to study protein …

Structure-Based Virtual Screening Protocol for in Silico Identification of Potential Thyroid Disrupting Chemicals Targeting Transthyretin

J Zhang, A Begum, K Brännström… - … science & technology, 2016 - ACS Publications
Thyroid disruption by xenobiotics is associated with a broad spectrum of severe adverse
outcomes. One possible molecular target of thyroid hormone disrupting chemicals (THDCs) …